Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 19, 2019 - Issue 4
Submit an article Journal homepage
708
Views
12
CrossRef citations to date
0
Altmetric
Drug Profile

Cariprazine for the treatment of bipolar depression: a review

Renee-Marie RagguettMood Disorders Psychopharmacology Unit, University Health Network, Toronto, CanadaView further author information
&
Roger S. McIntyreMood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada;Department of Psychiatry, University of Toronto, Toronto, Canada;Department of Pharmacology, University of Toronto, Toronto, CanadaCorrespondence[email protected]
View further author information
Pages 317-323 | Received 08 Nov 2018, Accepted 05 Feb 2019, Published online: 20 Feb 2019

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Rui-Xiang Yuan, Jun-Wei Xu, Lian-Hua Song, Yang-Li Qi, Hong Mou, Jian-Wei Wu, Ke-Yu Jiang & Xiao-Wen Chen. (2021) A convenient and practical synthesis of the cis isomer of the first orally active dopamine D3-Preferring D3-D2 receptor partial agonist cariprazine. Synthetic Communications 51:14, pages 2127-2134.
Read now

Articles from other publishers (11)

Luyao Cai, Guanjie Chen, Haichen Yang & Yuanhan Bai. (2023) Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review. International Clinical Psychopharmacology 38:4, pages 249-260.
Crossref
Hejian Tao, Jiawei Wang, Dong Shen, Fengli Sun & Weidong Jin. (2022) Is aripiprazole similar to quetiapine for treatment of bipolar depression? Results from meta-analysis of Chinese data. Frontiers in Psychiatry 13.
Crossref
Emanuela Dyrmishi, Marco De Pieri, Marco Ferrari, Rafael Traber, Matteo Preve, Luca De Peri & Emilio Bolla. (2022) Case Report: Long-Acting Oral Cariprazine. Frontiers in Psychiatry 13.
Crossref
Sahithi Madireddy & Samskruthi Madireddy. (2022) Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress–Induced Damage in Patients with Bipolar Disorder. International Journal of Molecular Sciences 23:3, pages 1844.
Crossref
Borjanka Batinic, Ivan Ristic, Milica Zugic & David S. Baldwin. (2021) Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine. Frontiers in Psychiatry 12.
Crossref
Jonathan M. Meyer & Stephen M. Stahl. 2021. The Clinical Use of Antipsychotic Plasma Levels. The Clinical Use of Antipsychotic Plasma Levels 337 371 .
Taichi Ochi, Natalya M. Vyalova, Innokentiy S. Losenkov, Diana Z. Paderina, Ivan V. Pozhidaev, Anton J. M. Loonen, German G. Simutkin, Nikolay A. Bokhan, Bob Wilffert & Svetlana A. Ivanova. (2021) Preliminary Pharmacogenetic Study to Explore Putative Dopaminergic Mechanisms of Antidepressant Action. Journal of Personalized Medicine 11:8, pages 731.
Crossref
Gabriella Nyitrai, Béla Kiss, Bence Farkas, Ottilia Balázs, Pálma Diószegi, Balázs Lendvai & András Czurkó. (2021) Cariprazine modulates sleep architecture in rats. Journal of Psychopharmacology 35:3, pages 303-310.
Crossref
Domenico De Berardis, Gabriella Rapini, Luigi Olivieri, Agostina Giardini, Ida De Lauretis, Nicola Serroni, Laura Orsolini, Michele Fornaro, Felice Iasevoli, Sabatino Trotta, Paolo Cottura, Federica Vellante, Marco Alessandrini & Massimo Di Giannantonio. (2021) Cariprazine Add-on in Inadequate Clozapine Response: A Report on Two Cases. Clinical Psychopharmacology and Neuroscience 19:1, pages 174-178.
Crossref
Ross J. Baldessarini, Gustavo H. Vázquez & Leonardo Tondo. (2020) Bipolar depression: a major unsolved challenge. International Journal of Bipolar Disorders 8:1.
Crossref
Jean-Michel Azorin & Nicolas Simon. (2019) Dopamine Receptor Partial Agonists for the Treatment of Bipolar Disorder. Drugs 79:15, pages 1657-1677.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.